These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 10220313)
41. Altering substrate specificity of phosphatidylcholine-preferring phospholipase C of Bacillus cereus by random mutagenesis of the headgroup binding site. Antikainen NM; Hergenrother PJ; Harris MM; Corbett W; Martin SF Biochemistry; 2003 Feb; 42(6):1603-10. PubMed ID: 12578373 [TBL] [Abstract][Full Text] [Related]
42. Mutagenesis of Glycine 179 modulates both catalytic efficiency and reduced pyridine nucleotide specificity in cytochrome b5 reductase. Roma GW; Crowley LJ; Davis CA; Barber MJ Biochemistry; 2005 Oct; 44(41):13467-76. PubMed ID: 16216070 [TBL] [Abstract][Full Text] [Related]
43. Drug metabolism by Escherichia coli expressing human cytochromes P450. Parikh A; Gillam EM; Guengerich FP Nat Biotechnol; 1997 Aug; 15(8):784-8. PubMed ID: 9255795 [TBL] [Abstract][Full Text] [Related]
44. Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. van Vugt-Lussenburg BM; Stjernschantz E; Lastdrager J; Oostenbrink C; Vermeulen NP; Commandeur JN J Med Chem; 2007 Feb; 50(3):455-61. PubMed ID: 17266197 [TBL] [Abstract][Full Text] [Related]
45. Purification, molecular cloning, heterologous expression and characterization of pig CYP1A2. Messina A; Chirulli V; Gervasi PG; Longo V Xenobiotica; 2008 Dec; 38(12):1453-70. PubMed ID: 18949657 [TBL] [Abstract][Full Text] [Related]
46. Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis. Lewis BC; Mackenzie PI; Miners JO Arch Biochem Biophys; 2007 Dec; 468(1):58-69. PubMed ID: 17959138 [TBL] [Abstract][Full Text] [Related]
47. Membrane topology of NADPH-cytochrome P450 reductase on the endoplasmic reticulum. Kida Y; Ohgiya S; Mihara K; Sakaguchi M Arch Biochem Biophys; 1998 Mar; 351(2):175-9. PubMed ID: 9515054 [TBL] [Abstract][Full Text] [Related]
48. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase. Aryal P; Yoshikawa K; Terashita T; Guengerich FP; Shimada T; Oda Y Mutat Res; 1999 Jun; 442(2):113-20. PubMed ID: 10393280 [TBL] [Abstract][Full Text] [Related]
49. Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2. Guengerich FP; Krauser JA; Johnson WW Biochemistry; 2004 Aug; 43(33):10775-88. PubMed ID: 15311939 [TBL] [Abstract][Full Text] [Related]
50. Extending the diversity of cytochrome P450 enzymes by DNA family shuffling. Rosic NN; Huang W; Johnston WA; DeVoss JJ; Gillam EM Gene; 2007 Jun; 395(1-2):40-8. PubMed ID: 17400405 [TBL] [Abstract][Full Text] [Related]
51. Distal site and surface mutations of cytochrome P450 1A2 markedly enhance dehalogenation of chlorinated hydrocarbons. Yanagita K; Sagami I; Shimizu T Arch Biochem Biophys; 1997 Oct; 346(2):269-76. PubMed ID: 9343374 [TBL] [Abstract][Full Text] [Related]
52. Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase. Cho H; Hamza A; Zhan CG; Tai HH Arch Biochem Biophys; 2005 Jan; 433(2):447-53. PubMed ID: 15581601 [TBL] [Abstract][Full Text] [Related]
53. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA. McLean KJ; Scrutton NS; Munro AW Biochem J; 2003 Jun; 372(Pt 2):317-27. PubMed ID: 12614197 [TBL] [Abstract][Full Text] [Related]
54. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency. Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686 [TBL] [Abstract][Full Text] [Related]
55. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains. Josephy PD; Batty SM; Boverhof DR Environ Mol Mutagen; 2001; 38(1):12-8. PubMed ID: 11473383 [TBL] [Abstract][Full Text] [Related]
56. Development of a high-throughput genotoxicity assay using Umu test strains expressing human cytochrome P450s and NADPH-P450 reductase and bacterial O-acetyltransferase. Hori H; Hirata D; Fujii W; Oda Y Environ Mol Mutagen; 2017 May; 58(4):209-216. PubMed ID: 28436560 [TBL] [Abstract][Full Text] [Related]
57. Improving the activity of surface displayed cytochrome P450 enzymes by optimizing the outer membrane linker. Quehl P; Schüürmann J; Hollender J; Jose J Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):104-116. PubMed ID: 27814979 [TBL] [Abstract][Full Text] [Related]
58. Effect of mutations of ionic amino acids of cytochrome P450 1A2 on catalytic activities toward 7-ethoxycoumarin and methanol. Mayuzumi H; Sambongi C; Hiroya K; Shimizu T; Tateishi T; Hatano M Biochemistry; 1993 Jun; 32(21):5622-8. PubMed ID: 8504082 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase. Locuson CW; Ethell BT; Voice M; Lee D; Feenstra KL Drug Metab Dispos; 2009 Mar; 37(3):457-61. PubMed ID: 19074522 [TBL] [Abstract][Full Text] [Related]
60. Differential roles of Glu318 and Thr319 in cytochrome P450 1A2 catalysis supported by NADPH-cytochrome P450 reductase and tert-butyl hydroperoxide. Hiroya K; Murakami Y; Shimizu T; Hatano M; Ortiz de Montellano PR Arch Biochem Biophys; 1994 May; 310(2):397-401. PubMed ID: 7910007 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]